Amr Ramahi

Amr Ramahi

Auto-generated profile, based on publicly available information

Amr Ramahi

Internal Medicine, Saint Michael's Medical Center, Newark, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Hematology/Oncology and Stem Cell Therapy
Verified
Journal Article
Open access
PKParminder Kaur
Parminder Kaur
FQFiras Qaqa
Firas Qaqa
ARAmr Ramahi
Amr Ramahi
YSYezin Shamoon
Yezin Shamoon
MSMonisha Singhal
Monisha Singhal
BSBalraj Singh
Balraj Singh
Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection mainly present with upper and lower respiratory tract symptoms, with complications related to cytokine storm syndrome and acute respiratory distress syndrome. It has also been described to predispose to venous and arterial thromboembolism; however, limited published data is available regarding thrombosis in coronavirus disease 2019 (COVID-19). Here we are presenting a case of arterial thrombosis in a patient with COVID-19 and a systematic review on coagulopathy associated with COVID-19.

1 August 2020 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
KCKok Hoe Chan
Kok Hoe Chan
DTDivya Thimmareddygari
Divya Thimmareddygari
ARAmr Ramahi
Amr Ramahi
LALiana Atallah
Liana Atallah
NBNicholas G. Baranetsky
Nicholas G. Baranetsky
JSJihad Slim
Jihad Slim

1 January 2021 in International Journal of Critical Illness and Injury Science
Verified
Journal Article
Open access
PDF file
BSBalraj Singh
Balraj Singh
ARAmr Ramahi
Amr Ramahi
KCKok Hoe Chan
Kok Hoe Chan
PKParminder Kaur
Parminder Kaur
GGGunwant Guron
Gunwant Guron
HSHamid Shaaban
Hamid Shaaban
Cholangiocarcinoma (CCA) is a rare cancer of the bile duct epithelial cells and it commonly spreads to the regional lymph nodes, liver, and lungs. Bone metastasis has been reported in patients with CCA, involving both the axial and appendicular skeleton. Herein, we report a case of extrahepatic CCA with extensive bone metastases involving the calvarium, sternum, bilateral ribs and scapulae, entire spine, pelvis, and bilateral femur. To our knowledge, this is the first case report on sternum metastasis in CCA. The case presentation and review of literature highlighted the rarity of this metastasis, and health-care providers should be aware of the rare presentation of CCA.

21 April 2020 in Cureus
Verified
Journal Article
Open access
PDF file
KCKok Hoe Chan
Kok Hoe Chan
SLSaraswathi Lakkasani
Saraswathi Lakkasani
ARAmr Ramahi
Amr Ramahi
HSHamid S. Shaaban
Hamid S. Shaaban
The emergence of immune checkpoint inhibitors (ICIs) in recent years has transformed the landscape of the management of solid tumors. The advancement of immunotherapy has resulted in a brand new set of adverse outcomes not previously seen in classical chemotherapy. One such adverse effect has been termed as hyperprogressive disease (HPD), a phenomenon characterized by rapid tumor progression, which often leads to devastating outcomes. In this report, we present a unique case of a 48-year-old African American female who initially presented with abdominal pain, fatigue, and weight loss. Subsequent CT scan showed extensive irregular wall and luminal narrowing with an eccentric mass and adenopathy along the portacaval space. Tumor markers were found to be elevated and genetic testing was done. The patient was diagnosed with stage IIIC colon cancer with K-RAS wild type, associated with Lynch syndrome. The patient underwent surgical resection, chemotherapy, and targeted therapy for progressive/stage IV disease. In light of the progression of the disease, pembrolizumab was introduced into the treatment regimen. One month after the treatment, a repeat CT scan showed enlargement of the metastatic lesion with almost double the size. The progression of the disease was so rapid and, ultimately, pembrolizumab administration was withheld and the patient passed away after about two months on pembrolizumab. To our knowledge, this is one of the few cases of HPD reported in patients with advanced colon cancer, particularly in one with Lynch syndrome. Further studies are warranted to understand why some individuals benefit from immunotherapy, whereas others experience grave outcomes.

22 March 2020 in Cureus
Verified
Journal Article
Open access
PDF file
KCKok Hoe Chan
Kok Hoe Chan
ARAmr Ramahi
Amr Ramahi
Starvation-induced ketoacidosis in non-diabetic and non-pregnant, otherwise healthy patients is not common. In an otherwise normal healthy individual, short-term starving will only result in mild ketosis. Nonetheless, the effects of ketosis can become more severe if there is stress and insulin resistance, such as in pregnant or lactating woman or in very young individual such as neonates. We report a case of severe starvation-induced ketoacidosis in a non-diabetic and non-pregnant 37-year-old African American female patient with a history of multiple recurrent pancreatitis. The patient was initially presented to the emergency department with abdominal pain, nausea and vomiting over two days. The patient also reported starving for two days prior to admission. Biological findings, however, showed a severe degree of metabolic acidosis with an increased anion gap. Serum glucose was normal and 3+ ketonuria were present. Lactic acid was 1.7 mmol/L with no uremia. Salicylate acid, acetaminophen and ethanol level were normal. The patient’s beta-hydroxybutyrate level elevated with ketonuria, suggestive of ketoacidosis as the cause of metabolic acidosis. To our knowledge, the presenting case was novel as no case reports or case series have been reported in these groups of patients. Short-term starvation, if it occurs during periods of stress and medication, may result in life-threatening ketoacidosis, even among non-diabetic women and non-pregnant patients. Awareness of this condition may facilitate prompt recognition and proactive treatment for dietary and stress control.

1 April 2021 in International Journal of Critical Illness and Injury Science
Verified
Journal Article
Open access
PDF file
ARAmr Ramahi
Amr Ramahi
KCKok Hoe Chan
Kok Hoe Chan
SLSu Lin Lim
Su Lin Lim
HSHamid S. Shaaban
Hamid S. Shaaban
Hepatocellular carcinoma (HCC) is ranked the fifth-most common cancer in men and ninth most common cancer in women. Immunotherapy has been shown effective in malignancies refractory to chemotherapy and has been used as a second-line therapies in many advanced cancers, including HCC. The advent of immunotherapy has resulted in a brand-new set of side effects, and it has been proposed that it was related to over activated immune system. Herein, we presented the case of 59-year-old African American gentlemen who was diagnosed with HCC caused by Hepatitis C virus, for which he was started on chemotherapy and immunotherapy. However, the patient developed cryoglobulinemia that prompted stopping both therapies and giving rituximab and steroids. We believe that the mixed cryoglobulinemia was unmasked by immunotherapy in our patient. To our knowledge, this is one of the few first cases to describe such adverse effect from immune checkpoint inhibitors.